1. Home
  2. AGL vs FEED Comparison

AGL vs FEED Comparison

Compare AGL & FEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo agilon health inc.

AGL

agilon health inc.

HOLD

Current Price

$80.72

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

FEED

ENvue Medical Inc. Common Stock

N/A

Current Price

$0.92

Market Cap

4.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AGL
FEED
Founded
2016
2003
Country
United States
United States
Employees
N/A
14
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
4.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
AGL
FEED
Price
$80.72
$0.92
Analyst Decision
Hold
Analyst Count
12
0
Target Price
$55.68
N/A
AVG Volume (30 Days)
555.5K
395.7K
Earning Date
05-06-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.94
N/A
Revenue
$5,932,576,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.23
N/A
P/E Ratio
$30.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.91
52 Week High
$90.48
$6.09

Technical Indicators

Market Signals
Indicator
AGL
FEED
Relative Strength Index (RSI) 78.35 28.39
Support Level $0.63 N/A
Resistance Level N/A $1.54
Average True Range (ATR) 8.71 0.13
MACD 3.52 -0.01
Stochastic Oscillator 87.14 10.66

Price Performance

Historical Comparison
AGL
FEED

About AGL agilon health inc.

Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.

About FEED ENvue Medical Inc. Common Stock

ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.

Share on Social Networks: